|
|
Article: "MIV Therapeutics (OTCBB:MIVT)" completes strategic acquisition of "BioSync Scientific"; aims to become world leader in $8B industry...
- Article from:
- M2 Presswire
- Article date:
- February 19, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-19 February 2007-Business to Leisure Monthly: "MIV Therapeutics (OTCBB:MIVT)" completes strategic acquisition of "BioSync Scientific"; aims to become world leader in $8B industry...(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:19022007
BTLMonthly.com has a Monthly Magazine, a Mid-Month Edition, and a Daily News Bulletin that features undervalued companies poised for growth. BTLMonthly.com features the Top Reasons to watch said companies.
Top 7 Reasons to Watch MIV Therapeutics, Inc. (OTCBB:MIVT):
1. HUGE MARKET - the total cardiovascular stent market in 2005 was approximately $7 billion in 2005.
2. PRODUCT RECOGNITION ...